Head-to-head · Value Score
CoreAge Rx vs Medivive
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Medivive a 63. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameMedivive
#335 · Grade C · Watch List
Est. first month
From $162/mo (compounded)
Save ~88% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 63 — an est. $149/mo first month, with no teaser step-up baked in. Medivive isn't out of it: Shoppers who want all-in-one telehealth shoppers exploring compounded GLP-1 alongside TRT, NAD+ and longevity care.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Medivive |
|---|---|---|
| Value Score | 93 (A+) | 63 (C) |
| Est. first month | $149/mo | From $162/mo (compounded) |
| Save vs brand-name | ~89% | ~88% |
| Semaglutide | $149/mo | Not disclosed |
| Tirzepatide | $349/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Medivive
Medivive is a US telehealth service offering compounded semaglutide and tirzepatide for weight loss, filled through a licensed pharmacy, with providers licensed in all 50 states and no insurance required.
Why it's a deal
- Compounded semaglutide and tirzepatide with providers licensed in all 50 states
- No insurance required; one-stop for GLP-1 plus TRT, NAD+ and longevity care
- Medication filled through a licensed pharmacy
The fine print
- Monthly pricing not published; disclosed only after an AI intake
- No legal entity or named pharmacy disclosed
- Service states are not individually listed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives board, and the same list for the other side is on alternatives to Medivive.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.